WallStreetZenWallStreetZen

NASDAQ: RCEL
Avita Medical Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RCEL

Based on 3 analysts offering 12 month price targets for Avita Medical Inc

Min Forecast
$14.00+152.71%
Avg Forecast
$18.00+224.91%
Max Forecast
$21.00+279.06%

Should I buy or sell RCEL stock?

Based on 3 analysts offering ratings for Avita Medical Inc.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RCEL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RCEL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their RCEL stock forecasts and price targets.

RCEL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-10
lockedlocked$00.00+00.00%2025-01-08
lockedlocked$00.00+00.00%2024-12-24

1 of 1

Forecast return on equity

Is RCEL forecast to generate an efficient return?

Forecast return on assets

Is RCEL forecast to generate an efficient return on assets?

Company
-7.79%
Industry
10.5%
RCEL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RCEL earnings per share forecast

What is RCEL's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.01
Avg 2 year Forecast
-$0.21

RCEL revenue forecast

What is RCEL's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$100.1M+39.74%
Avg 2 year Forecast
$136.1M+89.92%
RCEL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RCEL revenue growth forecast

How is RCEL forecast to perform vs Medical Devices companies and vs the US market?

Company
39.74%
Industry
7.53%
Market
55.62%
RCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RCEL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RCEL vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
RCEL$5.54$18.00+224.91%Strong Buy
LNSR$12.50$15.00+20.00%Hold
CVRX$5.86$14.60+149.15%Buy
RPID$3.55$8.00+125.35%Strong Buy
ANIK$10.93$19.00+73.83%Buy
View Top Medical Device Stocks

Avita Medical Stock Forecast FAQ

Is Avita Medical Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: RCEL) stock is to Strong Buy RCEL stock.

Out of 3 analysts, 3 (100%) are recommending RCEL as a Strong Buy, 0 (0%) are recommending RCEL as a Buy, 0 (0%) are recommending RCEL as a Hold, 0 (0%) are recommending RCEL as a Sell, and 0 (0%) are recommending RCEL as a Strong Sell.

If you're new to stock investing, here's how to buy Avita Medical stock.

What is RCEL's earnings growth forecast for 2025-2026?

(NASDAQ: RCEL) Avita Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 39.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Avita Medical's earnings in 2025 is -$57,046,000.On average, 3 Wall Street analysts forecast RCEL's earnings for 2025 to be -$26,699,005, with the lowest RCEL earnings forecast at -$32,250,283, and the highest RCEL earnings forecast at -$21,676,420.

In 2026, RCEL is forecast to generate -$5,419,105 in earnings, with the lowest earnings forecast at -$6,079,971 and the highest earnings forecast at -$4,758,238.

What is RCEL's revenue growth forecast for 2025-2026?

(NASDAQ: RCEL) Avita Medical's forecast annual revenue growth rate of 39.74% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.

Avita Medical's revenue in 2025 is $71,661,000.On average, 1 Wall Street analysts forecast RCEL's revenue for 2025 to be $2,647,166,652, with the lowest RCEL revenue forecast at $2,647,166,652, and the highest RCEL revenue forecast at $2,647,166,652.

In 2026, RCEL is forecast to generate $3,597,756,954 in revenue, with the lowest revenue forecast at $3,597,756,954 and the highest revenue forecast at $3,597,756,954.

What is RCEL's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: RCEL) forecast ROA is -7.79%, which is lower than the forecast US Medical Devices industry average of 10.5%.

What is RCEL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year RCEL price target, the average RCEL price target is $18.00, with the highest RCEL stock price forecast at $21.00 and the lowest RCEL stock price forecast at $14.00.

On average, Wall Street analysts predict that Avita Medical's share price could reach $18.00 by Jun 10, 2026. The average Avita Medical stock price prediction forecasts a potential upside of 224.91% from the current RCEL share price of $5.54.

What is RCEL's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: RCEL) Avita Medical's current Earnings Per Share (EPS) is -$2.19. On average, analysts forecast that RCEL's EPS will be -$1.01 for 2025, with the lowest EPS forecast at -$1.22, and the highest EPS forecast at -$0.82. In 2026, RCEL's EPS is forecast to hit -$0.21 (min: -$0.23, max: -$0.18).

What is RCEL's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: RCEL) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.